NCT00125957View on ClinicalTrials.gov

The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

December 31, 2011

Conditions
DepressionMajor Depressive DisorderUnipolar Depression
Interventions
DRUG

Wellbutrin

DRUG

Placebo

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

National Association for Research on Schizophrenia and Affective Disorders.

UNKNOWN

lead

Mclean Hospital

OTHER

NCT00125957 - The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression | Biotech Hunter | Biotech Hunter